The clearance of Cipla's Goa facility opens the doors for the launch of Abraxane, which could be a around $120 million opportunity at peak.

Leading drug maker Cipla shares today saw a steep rally of 10% after the USFDA classified its Goa facility as a Voluntary ...

With their innovative technology ASX medical imaging companies are capitalising on billions of dollars in contracts annually being awarded to companies by the US Department of Veterans Affairs.

Q1 2025 Earnings Conference Call November 4, 2024 5:00 PM ETCompany ParticipantsDavid Trone - SVP, IRJohn Hall - Chairman ...